Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study

Fig. 2

Boxplot of raw value of CRP over time (efficacy population).The teal diamond corresponds to the group arithmetic mean. The horizontal line in the box interior represents the group median. The length of the box represents the interquartile range (the distance between the 25th and 75th percentiles). The other symbols correspond to patient values

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us